Clinical trials
Active, not recruiting Multiple Myeloma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 8 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 6 |
| GlaxoSmithKline | 4 |
| Institute of Hematology & Blood Diseases Hospital, China | 3 |
| Sanofi | 3 |
| AbbVie | 2 |
| Bristol-Myers Squibb | 2 |
| Celgene | 1 |
| Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 1 |
| Hangzhou Sumgen Biotech Co., Ltd. | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 31 |
| Recurrence | 5 |
| Neoplasms | 2 |
| Hematologic Diseases | 1 |
| Hematologic Neoplasms | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Neoplasms, Plasma Cell | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.